Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Kolding – page 3

42 clinical trials in Kolding, Denmark. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Kolding at a glance
42
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

42 trials in Kolding

Open in trial search

Ischaemic stroke+2

Not recruiting

Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Asundexian
  • Sponsor:Bayer AG

Study of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Chronic kidney disease+1

Not recruiting

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Diabetic neuropathy+1

Not recruiting

Study of cagrilintide and semaglutide combination versus placebo in people with type 2 diabetes and painful diabetic peripheral neuropathy

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Study of GBS-NN/NN2 vaccine to prevent Group B streptococcus infection in healthy pregnant women: evaluating long-term immunity and booster dose safety during subsequent pregnancy

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Substances:GBS-NN
  • Sponsor:Minervax ApS

Study Comparing Rituximab and Ocrelizumab for Patients with Active Multiple Sclerosis

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ocrelizumab
  • Sponsor:Rigshospitalet

Myocardial infarction

Not recruiting

Study on the Effects of Carvedilol, Metoprolol Tartrate, and Bisoprolol Fumarate in Patients After a Heart Attack with Normal Heart Pumping Function

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bisoprolol Fumarate
  • Sponsor:Frederiksberg Hospital

Study on Hydralazine, Isosorbide Dinitrate, and Metformin for Patients with Chronic Heart Failure and Reduced Heart Function

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Isosorbide Dinitrate

Study on the Effects of Sparsentan and Irbesartan for Patients with Primary Focal Segmental Glomerulosclerosis (FSGS)

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Irbesartan
  • Sponsor:Travere Therapeutics Inc.

COVID-19

Not recruiting

Study on Anti-COVID-19 Hyperimmune Globulin for Treating Adults with Early COVID-19 Symptoms

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Anti-SARS-COV-2 polyclonal hyperimmune globulin
  • Sponsor:University Of Minnesota

Incontinence+1

Not recruiting

Study on Stopping Solifenacin and Mirabegron for Children with Daytime Urinary Incontinence

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Mirabegron
  • Sponsor:Region Midtjylland

Hip fracture

Not recruiting

Study on Preventing Constipation After Hip Fracture Surgery Using Bisacodyl and a Drug Combination for Post-Surgery Patients

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:65+ years
  • Substances:Bisacodyl
  • Sponsor:Odense University Hospital

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Kolding

What the registry says about research in the country

01 Cardiovascular and Renal Studies

Groundbreaking research focusing on chronic kidney disease treatments and cardiovascular conditions. Studies include innovative therapies for heart failure and stroke prevention in patients with atrial fibrillation.

  • Kidney disease management
  • Heart failure interventions
  • Stroke prevention strategies

Multiple trials examining new therapeutic approaches for improving patient outcomes in both acute and chronic conditions.

02 Infectious Diseases Research

Comprehensive studies addressing various infectious conditions, including Staphylococcus aureus bacteremia and viral respiratory infections. Investigations into optimal antibiotic treatment durations and novel therapeutic approaches.

  • COVID-19 treatments
  • Bacterial infections
  • Antibiotic protocols

Focus on developing effective treatment strategies for both common and severe infections.

03 Critical Care Medicine

Advanced research in intensive care treatments and interventions. Studies include fluid management strategies and treatment protocols for critically ill patients.

  • Sepsis management
  • Fluid overload treatments
  • Critical care interventions

Innovative approaches to improving outcomes for patients requiring intensive care support.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.